| Field | Specification |
|---|---|
| Mfr No | |
| Alternative Names | J-591, MLN-591, huJ-591, HuJ591-DOTA, Rosopatamab tetraxetan, CAS: 2260767-49-3 |
| Assay Type | |
| Cas No. | |
| Detection Method | |
| Detection Range | |
| Product Type | |
| Reactivity | |
| Sample Type(s) | Plasma, Serum |
| Shipping | |
| Storage | |
| Target |
Overview
Anti-Rosopatamab ELISA Kit is an ELISA-based immunoassay designed for quantitative measurement of Rosopatamab in research samples. It is commonly used to generate traceable concentration data for biomarker discovery, pathway studies, and comparative analyses across experimental conditions.
Key elements and design rationale
- Assay format: Quantitative Colorimetric ELISA. The format defines how signal scales with analyte abundance and how results are interpreted across a standard curve.
- Working range and sensitivity: dynamic range 7.81 - 500 ng/mL. Use these values to plan dilutions and keep readouts within the linear portion of the calibration curve.
- Sample compatibility: Intended for Plasma, Serum matrices. As with most immunoassays, matrix composition can influence apparent signal and should be evaluated with dilution linearity and spike-recovery concepts.
- Recovery reference: Typical recovery is reported as 80-120%. Recovery helps assess whether the sample matrix interferes with detection of spiked analyte.
This kit is supplied for research use in laboratory settings where defined, quantitative readouts are needed for experimental interpretation.
Biological background
Rosopatamab is a commonly studied research analyte. Its biological roles and regulation can be context-dependent (cell type, tissue state, and experimental perturbation). For authoritative gene/protein function summaries and nomenclature, researchers typically consult curated databases.
Research relevance and current trends
- Biomarker translation in RUO settings: Increasing use of quantitative immunoassays to stratify experimental cohorts, track longitudinal changes, and benchmark model systems.
- Matrix-aware assay design: Greater emphasis on dilution linearity, spike-recovery, and control concepts to reduce matrix-driven artifacts in serum/plasma and complex lysates.
- Integration with multi-omics: ELISA measurements are often used alongside transcriptomics and proteomics to connect abundance changes with pathway activity and phenotype.
Common research applications
- Comparative quantification: Measure relative changes in analyte levels across treatments, time points, or genotypes to support mechanistic hypotheses.
- Assay development and standardization: Generate reproducible concentration inputs for method qualification, inter-operator comparisons, or bridging studies across platforms.
- Model and sample characterization: Profile baseline and stimulated levels to help interpret immune, endocrine, neurodegenerative, or metabolic phenotypes (as relevant to the target).
Interpretation typically focuses on direction and magnitude of change in the context of controls and sample handling metadata, rather than single-point absolute values.
Notes for experimental interpretation
- Matrix effects: Hemolysis, lipemia, and high protein content can alter background and apparent concentration. Consider consistent collection/processing and evaluate dilution behavior.
- Isoforms and modified forms: Some targets exist as isoforms, fragments, or post-translationally modified species. Ensure the measured form aligns with the biological question and the kit’s intended analyte definition.
- Control concepts: Use negative/blank controls, replicate wells, and—when feasible—orthogonal confirmation (e.g., WB or MS) to strengthen conclusions.
What is an Anti-Drug Antibody (ADA) ELISA kit and what does this kit measure?
An ADA ELISA kit detects antibodies generated by the immune system in response to a biologic drug ? a phenomenon called immunogenicity. This kit is designed to quantitatively measure Rosopatamab in Human samples, supporting immunogenicity assessment for Rosopatamab treatment studies.
What sample matrices are validated for this assay?
This ADA kit has been validated for Plasma and Serum from Human subjects. Serum is generally preferred over plasma for ADA assays due to lower background. If plasma is used, the anticoagulant type (EDTA, heparin, citrate) should be documented as it may affect assay performance.
What is the assay sensitivity and quantification range?
The quantification range spans 7.81 - 500 ng/mL. Samples with ADA titers above the upper limit should be further diluted and re-assayed. Drug tolerance and drug interference should be evaluated for samples from treated subjects.
How does this ADA kit differ from a standard antigen ELISA?
Unlike a standard ELISA that captures a soluble analyte (e.g., a protein biomarker), this ADA assay is designed to capture circulating antibodies directed against Rosopatamab. The assay typically uses the drug itself as the capture and detection reagent (bridging format), ensuring detection of all immunoglobulin isotypes (IgG, IgM, IgA, IgE) that bind the drug.
Is drug interference a concern in ADA assays?
Yes. Residual Rosopatamab drug in patient samples can compete with the assay capture reagent and suppress ADA signal ? a phenomenon known as drug interference or drug tolerance. The kit's drug tolerance level should be referenced in the datasheet. Acid dissociation pre-treatment can be used in some formats to improve sensitivity in the presence of drug.
Can this kit be used to support regulatory immunogenicity studies?
This kit is for research use only (RUO). For regulated bioanalytical studies (e.g., IND/BLA submissions), ADA assays must be validated under FDA/EMA immunogenicity guidance (2019 FDA Guidance on Immunogenicity; EMA/CHMP/BMWP/86289/2010). This kit may serve as a starting point for method development, but full GLP validation by a qualified bioanalytical laboratory is required.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
